pt-112
Small moleculeexperimental
Clinical trial activity
7 trials · 11 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2014 (NCT02266745)
Timeline
Indications
Studied for
- Biliary Tract Neoplasms · Phase 1/Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 1/Phase 2
- Drugs, Investigational · Phase 1
- Genital Neoplasms, Male · Phase 1
- Multiple Myeloma · Phase 1
- Neoplasms · Phase 1/Phase 2
- Neoplasms by Site · Phase 1
- Prostatic Neoplasms · Phase 1
- Prostatic Neoplasms, Castration-Resistant · Phase 1
- Thymoma · Phase 2
- Thymus Neoplasms · Phase 2
- Urogenital Neoplasms · Phase 1
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pt-112
- pt-112
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05104736 | Phase 2 | Dec 7, 2021 | National Cancer Institute (NCI) |
| NCT05357196 | Phase 1/Phase 2 (Phase 2) | Apr 13, 2020 | Fudan University, SciClone Pharmaceuticals |
| NCT03409458 | Phase 1/Phase 2 (Phase 2) | Apr 24, 2018 | Merck Serono, Pfizer, Phosplatin Therapeutics, University of Texas at Houston |
| NCT03439761 | Phase 1/Phase 2 (Phase 2) | Mar 7, 2018 | Huazhong University of Science and Technology, SciClone Pharmaceuticals |
| NCT03288480 | Phase 1 | Dec 15, 2017 | Mayo Clinic, Phosplatin Therapeutics |
| NCT02884479 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2016 | National Cheng Kung University, Parexel, SciClone Pharmaceuticals |
| NCT02266745 | Phase 1 | Jul 1, 2014 | Phosplatin Therapeutics, University of Texas at Houston |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (11)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Phosplatin Therapeutics | For profit | 3 | 3 | 2 | 2014 |
| SciClone Pharmaceuticals | For profit | 3 | 3 | 1 | 2016 |
| University of Texas at Houston | Academic/Hospital | 2 | 0 | 2 | 2014 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Mayo Clinic | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Merck Serono | For profit | 1 | 0 | 1 | 2018 |
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 2021 |
| National Cheng Kung University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Parexel | For profit | 1 | 0 | 1 | 2016 |
| Pfizer | For profit | 1 | 0 | 1 | 2018 |
11 organizations
Page 1 / 1